Skip to content
2000
Volume 8, Issue 1
  • ISSN: 2452-2716
  • E-ISSN: 2452-2724

Abstract

Aims

To check the release efficacy of active pharmaceutical ingredients from tablet dosage form using synthetic and natural polymers.

Introduction

Diclofenac sodium in sustained release manner tablets was created by Xanthan gum, HPMC, and mixed with both polymers to change the concentration ratio. The dosage form of the tablet was examined for the early stage formulation studies such as repose angle, apparent density, compressibility index, and some corporal properties like weight variant, friability, and content of the drug. For post-formulation studies, like studies were implemented in a solution of phosphate buffer pH 7.4 for 8 hours. All the corporal properties of the diclofenac sodium tablets were within the limit of tolerance.

Objective

The study checked the Diclofenac Sodium release kinetics from synthetic and natural polymer-modified tablets.

Methods

Following the wet granulation method, we prepared a diclofenac sodium tablet using HPMC and Xanthan Gum Polymer.

Results

The tablet that contained both HPMC and Xanthan gum (Batch C-I and C-II) shows the best drug content than other polymer-based batches like HPMC (Batch A-I, A-II) and Xanthan gum (Batch B-I, B-II). The great sustained drug release was shown in the HPMC and Xanthan gum mixed polymer-based matrix tablet (Batch C-I). The data showed that the mixing of polymers could lead to sustaining drug release from the formulation.

Conclusion

From the research, we can conclude that the diclofenac release % was maximum when we used a combination of both polymers in the tablet dosage form.

Loading

Article metrics loading...

/content/journals/caps/10.2174/0124522716329448241226062454
2025-01-30
2025-10-28
Loading full text...

Full text loading...

References

  1. MartindaleC. The complete drug reference.LondonPharmaceutical press2009
    [Google Scholar]
  2. GoodmanL.S. Goodman and Gilman’s the pharmacological basis of therapeutics.New YorkMcGraw-Hill1996
    [Google Scholar]
  3. AlshargabiA. Diclofenac derivatives as promising anticancer and anti-inflammatory drug: Synthesis, formulations, and pharmacokinetics.J. Drug Deliv. Sci. Technol.20249510554410.1016/j.jddst.2024.105544
    [Google Scholar]
  4. ChaurasiaS. MishraB. Synthetic polymers as biomaterials for the treatment of colon diseases. Adv Drug Deliv Syst Colonic Disord.Academic Press20249513010.1016/B978‑0‑443‑14044‑0.00018‑1
    [Google Scholar]
  5. JainS JainA JainR ChouhanN.S Potential of natural polymeric materials in pharmaceutics.Pharmaco Res – Nat Pro2024210001410.1016/j.prenap.2024.100014
    [Google Scholar]
  6. YasminT. MahmoodA. FarooqM. Development and evaluation of a pH-responsive Mimosa pudica seed mucilage/β- cyclodextrin-co-poly(methacrylate) hydrogel for controlled drug delivery: In vitro and in vivo assessment.Int. J. Biol. Macromol.2024268Pt 213183210.1016/j.ijbiomac.2024.13183238663704
    [Google Scholar]
  7. SanjanwalaD. MehtaN.V. PatravaleV. Pharmaceutical polymers for modified drug delivery and controlled release.Polym Pharm Biomed Appl202419926010.1016/B978‑0‑323‑95496‑9.00006‑5
    [Google Scholar]
  8. MarquesP.A.C. GuerraN.B. dos SantosL.S. Natural rubber latex-based biomaterials for drug delivery and regenerative medicine: Trends and directions.Int. J. Biol. Macromol.2024267Pt 213166610.1016/j.ijbiomac.2024.13166638636755
    [Google Scholar]
  9. BartoníkováK. ŠpaglováM. PapadakosM. HankoM. MachoO. Mucoadhesive vaginal tablets containing metronidazole: Screening of optimal natural polymer in the composition.Sci. Pharm.20249211010.3390/scipharm92010010
    [Google Scholar]
  10. ZhouY. GuoL. DaiG. An overview of polymeric nanoplatforms to deliver veterinary antimicrobials.Nanomaterials (Basel)202414434110.3390/nano1404034138392714
    [Google Scholar]
  11. DuJ. XuK. YangX. DongZ. ZhaoL. Removal of diclofenac sodium from aqueous solution using different ionic liquids functionalized tragacanth gum hydrogel prepared by radiation technique.Int. J. Biol. Macromol.2024265Pt 113075810.1016/j.ijbiomac.2024.13075838462106
    [Google Scholar]
  12. AzimA. ShuvoS.H. EftyS.S. ShahruzzamanM. RahmanM.M. 16 - Ionotropic cross-linked drug delivery carriers made of grafted biopolymers.Ionot Cross-Link Biopolym202449153210.1016/B978‑0‑323‑96116‑5.00017‑X
    [Google Scholar]
  13. AskariV.R. FadaeiM.S. DabbaghiM.M. FadaeiM.R. RahimiV.B. 9 - Ionotropical cross-linked carboxymethylated gums-based systems in drug delivery.Ionot Cross-Link Biopolym202424527410.1016/B978‑0‑323‑96116‑5.00022‑3
    [Google Scholar]
  14. ElkadyE. FouadM. MozayadA. Application of box–behnken design and response surface methodology for selecting the optimum RP-HPLC conditions for the simultaneous determination of paracetamol and diclofenac sodium along with three skeletal muscle relaxants in three different pharmaceutical dosage forms.J. Chromatogr. Sci.202462432833810.1093/chromsci/bmad05137525524
    [Google Scholar]
  15. SzoleczkyR. KovácsA. BerkóS. Budai-SzűcsM. An analytical target profile for the development of an in vitro release test method and apparatus selection in the case of semisolid topical formulations.Pharmaceutics202416331310.3390/pharmaceutics1603031338543207
    [Google Scholar]
  16. PeetersM. Barrera JiménezA.A. MatsunamiK. Analysis of the effect of formulation properties and process parameters on granule formation in twin-screw wet granulation.Int. J. Pharm.202465012367110.1016/j.ijpharm.2023.12367138065345
    [Google Scholar]
  17. KumarN.R. RaoG.S.N.K. RatnaJ.V. MurthyK.V.R. Exploring the potential of neem and tamarind gum as release retardants: Design and statistical optimisation of vildagliptin extended release matrix systems using D-optimal quadratic mixture design.Int. J. Biol. Macromol.2024259Pt 112913610.1016/j.ijbiomac.2023.12913638181924
    [Google Scholar]
  18. JaiswalH. AnsariM.T. MahmoodT. AhsanF. AnsariV.A. AhmadU. Aceclofenac loaded microspheres: Formulation and evaluation of novel preprogrammed drug delivery for the treatment of arthritis.Intelligent Pharmacy202421698210.1016/j.ipha.2023.10.010
    [Google Scholar]
  19. AshokbhaiM.K. SanjayL.R. SahS.K. RoyS. KaityS. Premix technologies for drug delivery: Manufacturing, applications, and opportunities in regulatory filing.Drug Discov. Today202429610401110.1016/j.drudis.2024.10401138705511
    [Google Scholar]
  20. GagliardiA. ChiarellaE. VociS. DIFUCOSIN: DIclofenac sodium salt loaded FUCOidan-SericIN nanoparticles for the management of chronic inflammatory diseases.Int. J. Pharm.202465512403410.1016/j.ijpharm.2024.12403438531433
    [Google Scholar]
  21. AkbariS. JafariF. HatamiH. Preparation and characterization of diclofenac transdermal patch using ethyl cellulose and polyvinyl alcohol by electrospinning.J. Drug Deliv. Sci. Technol.20249210535910.1016/j.jddst.2024.105359
    [Google Scholar]
  22. DharD. BasuS.S. SenguptaS. Enhanced photocatalytic degradation of diclofenac sodium and clioquinol by Sr-doped SnS nanoflakes: Performance, mechanism and degradation study.J. Environ. Chem. Eng.202412311270810.1016/j.jece.2024.112708
    [Google Scholar]
  23. GültekinY. KorkmazÇ. ÖztürkN. Preparation and evaluation of fast-dissolving albendazole sulfoxide and praziquantel-loaded polyvinylpyrrolidone nanofiber films by electrospinning.J. Drug Deliv. Sci. Technol.20249210530410.1016/j.jddst.2023.105304
    [Google Scholar]
  24. WongwadE. IngkaninanK. WaranuchN. Improved transdermal delivery of novel cannabinoid-loaded patches using Eudragit matrix.J. Drug Deliv. Sci. Technol.20249610569710.1016/j.jddst.2024.105697
    [Google Scholar]
  25. BhattiZ. PatelS. ShahS. ShahN. SavaniR. ChauhanS. Is diclofenac transbuccal mucoadhesive patch superior to oral diclofenac for the management of postoperative sequelae after third molar surgery?J. Oral Maxillofac. Surg.202482784085110.1016/j.joms.2024.03.01938615694
    [Google Scholar]
  26. GanesanM. SekarJ. RajendranA.S. SrinivasanP. A Splendid comprehension into in-silico and in-vitro biological investigations to assess the anti-inflammatory and anti-breast cancer activities of newly synthesized 1-Phenylethyl Quinoline-4-carboxylates.J. Mol. Struct.2024131113841110.1016/j.molstruc.2024.138411
    [Google Scholar]
/content/journals/caps/10.2174/0124522716329448241226062454
Loading
/content/journals/caps/10.2174/0124522716329448241226062454
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test